Analysts: Pacific Biosciences of California Inc (PACB.OQ)
PACB.OQ on NASDAQ Stock Exchange Global Select Market
2.67USD
1 Aug 2013
2.67USD
1 Aug 2013
Price Change (% chg)
$0.08 (+3.09%)
$0.08 (+3.09%)
Prev Close
$2.59
$2.59
Open
$2.64
$2.64
Day's High
$2.67
$2.67
Day's Low
$2.54
$2.54
Volume
28,380
28,380
Avg. Vol
88,908
88,908
52-wk High
$3.25
$3.25
52-wk Low
$1.09
$1.09
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Hold | -0.33 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 0 | 0 | 0 | 0 |
| (2) OUTPERFORM | 1 | 1 | 1 | 1 |
| (3) HOLD | 1 | 1 | 1 | 1 |
| (4) UNDERPERFORM | 3 | 3 | 3 | 3 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 3.40 | 3.40 | 3.40 | 3.40 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 4 | 7.34 | 8.00 | 6.68 | 4.48 |
| Quarter Ending Dec-13 | 4 | 8.35 | 9.00 | 7.22 | 5.26 |
| Year Ending Dec-13 | 5 | 27.23 | 29.00 | 26.25 | 23.51 |
| Year Ending Dec-14 | 5 | 34.84 | 40.94 | 29.50 | 25.17 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 5 | -0.33 | -0.25 | -0.38 | -0.42 |
| Quarter Ending Dec-13 | 5 | -0.33 | -0.28 | -0.38 | -0.42 |
| Year Ending Dec-13 | 5 | -1.37 | -1.22 | -1.50 | -1.65 |
| Year Ending Dec-14 | 5 | -1.18 | -0.77 | -1.48 | -1.49 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 5.29 | 5.58 | 0.29 | 5.42 |
| Quarter Ending Dec-12 | 4.38 | 5.88 | 1.50 | 34.12 |
| Quarter Ending Sep-12 | 3.12 | 2.78 | 0.34 | 10.98 |
| Quarter Ending Jun-12 | 6.89 | 7.29 | 0.40 | 5.82 |
| Quarter Ending Mar-12 | 7.11 | 10.04 | 2.92 | 41.11 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | -0.38 | -0.37 | 0.01 | -1.60 |
| Quarter Ending Dec-12 | -0.37 | -0.39 | 0.02 | -4.28 |
| Quarter Ending Sep-12 | -0.43 | -0.41 | 0.02 | -5.09 |
| Quarter Ending Jun-12 | -0.46 | -0.40 | 0.06 | -13.79 |
| Quarter Ending Mar-12 | -0.47 | -0.50 | 0.03 | -7.14 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 7.34 | 7.34 | 7.34 | 7.34 | 4.48 |
| Quarter Ending Dec-13 | 8.35 | 8.35 | 8.35 | 8.35 | 5.26 |
| Year Ending Dec-13 | 27.23 | 27.23 | 27.23 | 27.23 | 23.51 |
| Year Ending Dec-14 | 34.84 | 34.84 | 34.84 | 34.84 | 25.17 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | -0.33 | -0.33 | -0.33 | -0.33 | -0.42 |
| Quarter Ending Dec-13 | -0.33 | -0.33 | -0.33 | -0.33 | -0.42 |
| Quarter Ending Dec-13 | -1.37 | -1.37 | -1.37 | -1.37 | -1.65 |
| Quarter Ending Dec-14 | -1.18 | -1.18 | -1.18 | -1.18 | -1.49 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 1 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 1 | 1 |
| Year Ending Dec-14 | 0 | 0 | 1 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Wright Reports
|
$460.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates